Skip to content
Screener

Total Revenue at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$1.39B+9.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Staar Surgical logo
Staar SurgicalSTAA
$93.52M+120%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$12.49M+32.4%
Ardelyx logo
ArdelyxARDX
$120.88M+23.8%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$113.04M+32.6%

Segments

By segment

See full
Bausch + Lomb$1.24B+9.4%
Salix$639M+17.9%
International$285M+8.8%
Diversified$185M-9.8%
Solta Medical$171M+51.3%

Other financials

Income statement

See full
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenues
Product sales$2,500$2,227
Other revenues2432
2,5242,259
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets)721683
Cost of other revenues1718
Selling, general and administrative861867

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's total revenue?
Bausch Health Companies (BHC) reported total revenue of $2.52B in Q1 2026.
How has Bausch Health Companies's total revenue changed year-over-year?
Bausch Health Companies's total revenue increased by 11.7% year-over-year, from $2.26B to $2.52B.
What is the long-term trend for Bausch Health Companies's total revenue?
Over 4 years (2021 to 2025), Bausch Health Companies's total revenue has grown at a 5.0% compound annual growth rate (CAGR), from $8.43B to $10.27B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Bausch Health Companies's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude